Liver Institute of Virginia
Newport News, Virginia, United States
Specialized clinic in Newport News, Virginia
12720 McManus Blvd Suite 313, Newport News, VA 23602
About Liver Institute of Virginia
"Visit Bon Secours Liver Institute of Hampton Roads in Newport News, Virginia. Bon Secours Liver Institute of Hampton Roads is one of the many Liver Care Hepatology locations at Bon Secours providing good help to those in need."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
10
Conatus Pharmaceuticals Inc.
2
Mirum Pharmaceuticals, Inc.
2
Bristol-Myers Squibb
1
Calliditas Therapeutics AB
1
Celgene
1
CymaBay Therapeutics, Inc.
1
Exact Sciences Corporation
1
Galectin Therapeutics Inc.
1
Genfit
1
GlobeImmune
1
Clinical Trials at Liver Institute of Virginia
During the past decade, Liver Institute of Virginia conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection
2007-12-01
2012-11-01
Completed
140
Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Responders
2010-01-01
2011-12-01
Completed
67
A Study of BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype I
2010-07-01
2010-12-01
Withdrawn
0
A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
2010-10-01
2013-09-01
Completed
324
A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
2010-10-01
2013-09-01
Completed
245
Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders
2011-01-01
2011-10-01
Terminated
114
GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection
2011-05-01
2013-03-01
Completed
141
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype
2011-08-01
2013-06-01
Terminated
248
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Liver Institute of Virginia" #1 sponsor was "Gilead Sciences" with 10 trials, followed by "Conatus Pharmaceuticals Inc." with 2 trials
sponsored, "Mirum Pharmaceuticals, Inc." with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Calliditas Therapeutics AB"
with 1 trials sponsored. Other sponsors include 9 different institutions and
companies that sponsored additional 19 trials in total.
Clinical Trials Conditions at Liver Institute of Virginia
According to Clinical.Site data, the most researched conditions in "Liver Institute of Virginia" are
"Primary Biliary Cirrhosis" (5 trials), "Hepatitis C, Chronic" (4 trials), "NASH - Nonalcoholic Steatohepatitis" (3 trials), "Hepatitis C" (2 trials) and "Liver Fibrosis Due to NASH" (2 trials). Many other conditions were trialed in "Liver Institute of Virginia" in a lesser frequency.
Clinical Trials Intervention Types at Liver Institute of Virginia
Most popular intervention types in "Liver Institute of Virginia" are "Drug" (24 trials), "Biological" (5 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "GS-9451" (3 trials), "Ribavirin" (3 trials), "CTS-1027" (2 trials) and "Copegus®" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Liver Institute of Virginia
The vast majority of trials in "Liver Institute of Virginia" are
30 trials for "All" genders.
Clinical Trials Status at Liver Institute of Virginia
Currently, there are NaN active trials in "Liver Institute of Virginia".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 15 completed trials in Liver Institute of Virginia,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Liver Institute of Virginia, 0 "Phase 1"
clinical trials were conducted, 22 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".